DM199 for Pregnancy Complications
← catalyst calendarSponsored by DiaMedica Therapeutics Inc (industry) · DMAC — their whole pipeline →.
Phase
Not applicable
Status
Withdrawn
Study type
Interventional
Design
Na · None · Other
Enrollment
0actual
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
This entry was unauthorized and has been withdrawn.
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | May 2025 | estimated | When the study began enrolling |
| Primary completion | May 2025 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | May 2025 | estimated | The whole study's end, after follow-up |
| First posted | 2025-03-13 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-06-04 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Pre-Eclampsia
Intervention
- Biological: DM199
Primary outcome
what the primary-completion date above is the date OFIncidence of treatment adverse events
measured Until 6 weeks after the due date
Permalink · DMAC's whole pipeline · Catalyst calendar · Every registered study · What changed